Production approval of 6 kinds of cefmetazole sodium APIs for Fuan pharmaceutical industry

Fuan Pharmaceutical Co., Ltd announced in the evening of the 26th that the company's six kinds of chemical drugs "Cefmetazole sodium" APIs have recently been received from the State Food and Drug Administration One pharmaceutical production approval has been approved and issued, which is valid until December 16, 2018 Meanwhile, the company has also received the approval of clinical trial of "lekadipine hydrochloride tablets" and the notice of approval opinion of "lekadipine hydrochloride" issued by the State Food and drug administration, marking that the variety has officially entered the stage of bioequivalence test The data show that Cefmetazole sodium is the second generation cephalosporin antibiotic, which plays a bactericidal role by inhibiting the cell wall synthesis of bacteria in the proliferative stage Fu'an pharmaceutical said it will organize and arrange GMP certification of the drug as soon as possible, and strive to produce and sell the drug as soon as possible Lekadipine hydrochloride is a kind of cardiovascular system drug, and its tablets are chemical drugs of 6 categories and raw materials of 3 categories The relevant director of Fuan pharmaceutical said that it will organize and implement clinical trials as soon as possible in accordance with the requirements of the national drug clinical trials, and the process is expected to continue until the end of next year, after which it will apply for product production.